Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
IRadimed Corporation is a medical devices business based in the US. IRadimed Corporation shares (IRMD) are listed on the NASDAQ and all prices are listed in US Dollars. IRadimed Corporation employs 114 staff and has a trailing 12-month revenue of around USD$34.1 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$23.24 |
---|---|
52-week range | USD$14.415 - USD$28.43 |
50-day moving average | USD$23.9959 |
200-day moving average | USD$22.8266 |
Wall St. target price | USD$28 |
PE ratio | 73.0408 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$0.319 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $23.24 from 2021-01-11
1 week (2021-01-07) | -0.81% |
---|---|
1 month (2020-12-16) | -4.52% |
3 months (2020-10-16) | 5.93% |
6 months (2020-07-16) | -3.29% |
1 year (2020-01-16) | -11.06% |
---|---|
2 years (2019-01-16) | -11.43% |
3 years (2018-01-16) | 52.39% |
5 years (2016-01-15) | 12.05% |
Valuing IRadimed Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IRadimed Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IRadimed Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, IRadimed Corporation shares trade at around 73x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IRadimed Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IRadimed Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
IRadimed Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$4.8 million.
The EBITDA is a measure of a IRadimed Corporation's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$34.1 million |
---|---|
Operating margin TTM | 10.37% |
Gross profit TTM | USD$29.7 million |
Return on assets TTM | 3.32% |
Return on equity TTM | 7.06% |
Profit margin | 11.67% |
Book value | $4.949 |
Market capitalisation | USD$285.9 million |
TTM: trailing 12 months
There are currently 153,028 IRadimed Corporation shares held short by investors – that's known as IRadimed Corporation's "short interest". This figure is 5.6% down from 162,154 last month.
There are a few different ways that this level of interest in shorting IRadimed Corporation shares can be evaluated.
IRadimed Corporation's "short interest ratio" (SIR) is the quantity of IRadimed Corporation shares currently shorted divided by the average quantity of IRadimed Corporation shares traded daily (recently around 20458.288770053). IRadimed Corporation's SIR currently stands at 7.48. In other words for every 100,000 IRadimed Corporation shares traded daily on the market, roughly 7480 shares are currently held short.
However IRadimed Corporation's short interest can also be evaluated against the total number of IRadimed Corporation shares, or, against the total number of tradable IRadimed Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IRadimed Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 IRadimed Corporation shares in existence, roughly 10 shares are currently held short) or 0.0242% of the tradable shares (for every 100,000 tradable IRadimed Corporation shares, roughly 24 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against IRadimed Corporation.
Find out more about how you can short IRadimed Corporation stock.
We're not expecting IRadimed Corporation to pay a dividend over the next 12 months.
Over the last 12 months, IRadimed Corporation's shares have ranged in value from as little as $14.415 up to $28.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IRadimed Corporation's is 1.2058. This would suggest that IRadimed Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Everything we know about the Bakkt Holdings IPO, plus information on how to buy in.
Everything we know about the Dream Finders Homes Inc IPO, plus information on how to buy in.
Everything we know about the Q BioMed Inc IPO, plus information on how to buy in.
Everything we know about the Faraday Future IPO, plus information on how to buy in.
Everything we know about the TELUS International Inc IPO, plus information on how to buy in.
Everything we know about the Interior Logic Group Holdings LLC IPO, plus information on how to buy in.
Everything we know about the Evaxion Biotech IPO, plus information on how to buy in.
Everything we know about the ON24 Inc IPO, plus information on how to buy in.
Everything we know about the Home Point Capital Inc IPO, plus information on how to buy in.
Everything we know about the ALFI INC IPO, plus information on how to buy in.